indazoles has been researched along with guanosine 5'-o-(3-thiotriphosphate) in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boblewski, K; Ferdousi, M; Hudson, AL; Laurila, JM; Lehmann, A; Rybczyńska, A; Sączewski, F; Scheinin, M; Wasilewska, A | 1 |
| Auwärter, V; Grafinger, KE; Halter, S; Haschimi, B; Huppertz, LM; Psychou, E; Pulver, B; Pütz, M; Westphal, F | 1 |
2 other study(ies) available for indazoles and guanosine 5'-o-(3-thiotriphosphate)
| Article | Year |
|---|---|
Fluorinated analogues of marsanidine, a highly α2-AR/imidazoline I1 binding site-selective hypotensive agent. Synthesis and biological activities.
Topics: Antihypertensive Agents; Binding Sites; Blood Pressure; Chemistry Techniques, Synthetic; Drug Design; Guanosine 5'-O-(3-Thiotriphosphate); Halogenation; Heart Rate; Hemodynamics; Humans; Imidazolidines; Imidazolines; Indazoles; Receptors, Adrenergic, alpha-2; Substrate Specificity | 2014 |
New synthetic cannabinoids carrying a cyclobutyl methyl side chain: Human Phase I metabolism and data on human cannabinoid receptor 1 binding and activation of Cumyl-CBMICA and Cumyl-CBMINACA.
Topics: Biotransformation; Cannabinoid Receptor Agonists; Cannabinoids; Guanosine 5'-O-(3-Thiotriphosphate); Humans; Hydroxylation; Illicit Drugs; Indazoles; Indoles; Microsomes, Liver; Receptor, Cannabinoid, CB1 | 2021 |